<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000443020">
  <TermName>iodine I 131-monoclonal antibody BC8</TermName>
  <TermPronunciation>(I-oh-dine … MAH-noh-KLOH-nul AN-tee-BAH-dee…)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of some types of leukemia and lymphoma. BC8 is a monoclonal antibody that binds to a protein called CD45, which is found on most white blood cells and some types of leukemia and lymphoma cells. It is linked to a radioactive substance called iodine I 131, which may help kill cancer cells. Iodine I 131-monoclonal antibody BC8 is a type of radioimmunoconjugate.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000714629" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iodine I 131 monoclonal antibody BC8&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000714628" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;yodo I 131-anticuerpo monoclonal BC8&quot;" language="es" id="_4"/>
  <SpanishTermName>yodo I 131-anticuerpo monoclonal BC8</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de leucemia y linfoma. BC8 es un anticuerpo monoclonal que se une a una proteína que se llama CD45, que se encuentra en la mayoría de los glóbulos blancos y en algunos tipos de células de leucemia y linfoma. Se une a una sustancia radiactiva llamada yodo I 131 que es capaz de destruir células cancerosas. El yodo I 131-anticuerpo monoclonal BC8 es un tipo de radioinmunoconjugado.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-04-14</DateFirstPublished>
  <DateLastModified>2017-03-23</DateLastModified>
</GlossaryTerm>
